Suplatast tosilate

Suplatast tosilate

Suplatast tosilate is a Th2 cytokine inhibitor used primarily in the treatment of asthma and allergic rhinitis. It was first developed in Japan and is marketed under the brand name IPD-1151T.

Mechanism of Action

Suplatast tosilate works by selectively inhibiting the production of Th2 cytokines, which are a group of immune system proteins that play a key role in the development of allergic reactions. By reducing the levels of these cytokines, suplatast tosilate can help to control the symptoms of conditions like asthma and allergic rhinitis.

Uses

Suplatast tosilate is used in the treatment of several conditions, including:

• Asthma: Suplatast tosilate can help to control the symptoms of asthma by reducing inflammation in the airways.
• Allergic rhinitis: This medication can also be used to treat allergic rhinitis, a condition characterized by symptoms like sneezing, runny nose, and itchy eyes.

Side Effects

Like all medications, suplatast tosilate can cause side effects. These may include:

• Nausea
• Headache
• Abdominal pain
• Rash

Patients should contact their healthcare provider if they experience any unusual or severe side effects while taking suplatast tosilate.

See Also

• Th2 cytokine inhibitor
• Asthma
• Allergic rhinitis

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!